Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.21
-0.21 (-1.46%)
At close: Apr 25, 2025, 4:00 PM
14.15
-0.06 (-0.42%)
Pre-market: Apr 28, 2025, 7:44 AM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $576.39 million as of April 28, 2025. Its market cap has decreased by -73.67% in one year.
Market Cap
576.39M
Enterprise Value
35.32M
1-Year Change
-73.67%
Ranking
Category
Stock Price
$14.21
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $576.39M, an increase of 49.59%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 576.39M | -10.11% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |